Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Update! On high watch for Monday

$Longeveron (LGVN.US)$ Longeveron® Presents Study Results From Clear Mind Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (Aaic)! It met primary safety and secondary efficacy!
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
10
3
+0
20
Translate
Report
13K Views
Comment
Sign in to post a comment

View more comments...

3640Followers
23Following
54KVisitors
Follow